Senior insider sale
Chief Executive Officer at MOONLAKE IMMUNOTHERAPEUTICS — senior position signals high conviction
$5.79M
300K shares
What this filing means
SANTOS DA SILVA JORGE plans to sell 300K shares of MOONLAKE IMMUNOTHERAPEUTICS valued at approximately $5.79M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/30/2026ACC: 0001969223-26-000744
DirectorOfficer· Chief Executive Officer
Since Apr 2022
300K
Shares to sell
$5.79M
Approx. market value
150K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Exchange of shares
NA
4/5/2023
150KTotal acquired150K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/5/2023 | Exchange of shares NA | 150K | — |
| Total | 150K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
150K
Market value
$2.79M
4/10/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
150K
Market value
$3.00M
6/30/2026
Total
Units
300K
Value
$5.79M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/10/2026 | 150K | $2.79M | — | Completed |
| Planned — Approximate Date | ||||
6/30/2026 | 150K | $3.00M | Nasdaq | Planned |
| Total | 300K | $5.79M | ||